APA (7th ed.) Citation

Yu, Y., Lee, Y. C., Fang, Y., Hsieh, W., & Tsai, M. (2026). Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes. Journal of Diabetes Investigation, 17(5), 766. https://doi.org/10.1111/jdi.70281

Chicago Style (17th ed.) Citation

Yu, Yu‐Ting, Ying Chun Lee, Yu‐Wei Fang, Wen‐Hui Hsieh, and Ming‐Hsien Tsai. "Association of Glucagon‐like Peptide‐1 Receptor Agonist Use with Clinical Outcomes in Patients with Rheumatoid Arthritis and Type 2 Diabetes." Journal of Diabetes Investigation 17, no. 5 (2026): 766. https://doi.org/10.1111/jdi.70281.

MLA (9th ed.) Citation

Yu, Yu‐Ting, et al. "Association of Glucagon‐like Peptide‐1 Receptor Agonist Use with Clinical Outcomes in Patients with Rheumatoid Arthritis and Type 2 Diabetes." Journal of Diabetes Investigation, vol. 17, no. 5, 2026, p. 766, https://doi.org/10.1111/jdi.70281.